JAGX

Jaguar Health, Inc.

0.69

USD

JAGX Earnings Reports

Positive Surprise Ratio

JAGX beat 13 of 30 last estimates.

43%

Next Report

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

$4.30M

-$4.34

Implied change from Q3 25 (Revenue/ EPS)

+39.32%

-30.89%

Implied change from Q4 24 (Revenue/ EPS)

+23.96%

+1176.47%

Jaguar Health, Inc. earnings per share and revenue

On Nov 18, 2025, JAGX reported earnings of -6.28 USD per share (EPS) for Q3 25, missing the estimate of -5.18 USD, resulting in a -21.20% surprise. Revenue reached 3.08 million, compared to an expected 3.80 million, with a -18.97% difference. The market reacted with a -8.03% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -4.34 USD, with revenue projected to reach 4.30 million USD, implying an decrease of -30.89% EPS, and increase of 39.32% in Revenue from the last quarter.

FAQ

What were Jaguar Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Jaguar Health, Inc. reported EPS of -$6.28, missing estimates by -21.2%, and revenue of $3.08M, -18.97% below expectations.

How did the market react to Jaguar Health, Inc.'s Q3 2025 earnings?

The stock price moved down -8.03%, changed from $1.80 before the earnings release to $1.66 the day after.

When is Jaguar Health, Inc. expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for Jaguar Health, Inc.'s next earnings report?

Based on 3 analysts, Jaguar Health, Inc. is expected to report EPS of -$4.34 and revenue of $4.30M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.